EPM2A Antikörper (AA 131-144)

Produktnummer ABIN962654

Produktdetails anti-EPM2A Antikörper

Target: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Bindungsspezifität: AA 131-144

Reaktivität: Human, Ratte, Maus, Rind (Kuh), Hund, Schwein, Kaninchen, Affe, Fledermaus

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser EPM2A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Marke: IHC-plus™

Spezifität: Human EPM2A. This antibody is expected to recognize isoform a (NP_005661.1) only.

Homologie: Percent identity by BLAST analysis: Human, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Panda, Bovine, Bat, Dog, Rabbit, Pig, Opossum (100%) Xenopus (93%).

Aufreinigung: Immunoaffinity purified

Immunogen: Synthetic peptide C-EATGHTNEMKHTTD from an internal region of human EPM2A (NP_005661.1). Percent identity by BLAST analysis: Human, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Panda, Bovine, Bat, Dog, Rabbit, Pig, Opossum (100%), Xenopus (93%).

Type of Immunogen: Synthetic peptide

Anwendungsinformationen

Applikationshinweise: Approved: IHC, IHC-P (2.5 - 3.75 μg/mL), Peptide-ELISA (1:16000, 0.1 - 0.3 μg/mL), WB (0.1 - 0.3 μg/mL)

Usage: Peptide ELISA: antibody detection limit dilution 1:16000. Western Blot: Approx. 38kD band observed in Human Brain (Cerebellum), Mouse Brain and Rat Brain lysates (calculated MW of 37.2kD according to NP_005661.1). Recommended concentration: 0.1-0.3 μg/mL.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Tris-buffered saline,  pH 7.3, 0.5 % BSA, 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze-thaw cycles.

Details zu EPM2A

Target: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Andere Bezeichnung: EPM2A / Laforin (EPM2A Produkte)

Synonyme: TG-B antikoerper, Tg(TcraK,TcrbK)TG-BFlv antikoerper, EPM2 antikoerper, MELF antikoerper, laforin antikoerper, EPM2A, laforin glucan phosphatase antikoerper, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha antikoerper, EPM2A antikoerper, Epm2a antikoerper

Hintergrund: Name/Gene ID: EPM2A
Subfamily: Laforin
Family: Protein Phosphatase

Synonyms: EPM2A, EPM2, LAFPTPase, LDE, Lafora PTPase, MELF, Laforin, LD

Gen-ID: 7957

NCBI Accession: NP_005661

UniProt: O95278

Pathways: Cellular Glucan Metabolic Process